This topic contains a solution. Click here to go to the answer

Author Question: Which nondepolarizing neuromuscular blocker has the shortest duration of action? a. Pancuronium ... (Read 96 times)

misspop

  • Hero Member
  • *****
  • Posts: 540
Which nondepolarizing neuromuscular blocker has the shortest duration of action?
 
  a. Pancuronium
  b. Rocuronium
  c. Vecuronium
  d. Mivacurium

Question 2

The nurse is planning to obtain serum for a peak aminoglycoside level. When should the blood be drawn?
 
  a. 30 minutes after completing the infusion
  b. 2 hours after completing the infusion
  c. 4 hours after completing the infusion
  d. 12 hours after completing the infusion



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jxjsniuniu

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

d

Answer to Question 2

a




misspop

  • Member
  • Posts: 540
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


irishcancer18

  • Member
  • Posts: 310
Reply 3 on: Yesterday
Excellent

 

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library